Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$46.5 - $79.14 $5,301 - $9,021
-114 Reduced 0.97%
11,675 $550,000
Q2 2022

Aug 12, 2022

SELL
$63.06 - $84.75 $79,770 - $107,208
-1,265 Reduced 9.69%
11,789 $845,000
Q1 2022

May 13, 2022

BUY
$74.15 - $99.36 $359,998 - $482,392
4,855 Added 59.21%
13,054 $1.06 Million
Q4 2021

Feb 11, 2022

BUY
$86.01 - $102.89 $439,769 - $526,076
5,113 Added 165.68%
8,199 $842,000
Q3 2021

Nov 12, 2021

SELL
$84.7 - $96.31 $655,493 - $745,343
-7,739 Reduced 71.49%
3,086 $270,000
Q2 2021

Aug 13, 2021

BUY
$76.44 - $89.57 $827,463 - $969,595
10,825 New
10,825 $969,000
Q1 2021

May 14, 2021

SELL
$67.36 - $80.76 $289,513 - $347,106
-4,298 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$53.08 - $69.86 $488,070 - $642,362
-9,195 Reduced 68.15%
4,298 $293,000
Q3 2020

Nov 13, 2020

BUY
$51.29 - $65.09 $692,055 - $878,259
13,493 New
13,493 $717,000
Q2 2020

Aug 10, 2020

SELL
$34.32 - $62.43 $10,330 - $18,791
-301 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$32.64 - $73.63 $9,824 - $22,162
301 New
301 $12,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.